Spexis investor relations
WebMoved Permanently. The document has moved here. Web© 2024, Spexis Ltd., Hegenheimermattweg 125, 4123 Allschwil, Switzerland, T: +41 61 567 16 00, [email protected] – Disclaimer – Privacy Rules – Disclosure This site uses … > Investor Relations (placeholder) > Calendar. Corporate Calendar. May 31, … Spexis shares are traded on the SIX Swiss Stock Exchange. Investors wishing to … © 2024, Spexis Ltd., Hegenheimermattweg 125, 4123 Allschwil, Switzerland, T: +41 …
Spexis investor relations
Did you know?
WebFeb 6, 2024 · Investor Relations MC: 31742 301 E Market Street Indianapolis, IN 46204 Investor Relations Cummins Inc. Chris Clulow Vice President, Investor Relations T: 812-377-3121 [email protected] [email protected] Transfer Agent Broadridge Shareholder Services T: 1-844-973-0592 [email protected] WebJun 30, 2024 · ALLSCHWIL, Switzerland, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced its financial results for the first half of 2024 and provided a strategic business update.
WebAug 31, 2024 · ALLSCHWIL, Switzerland, Aug. 31, 2024 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced that the Company... WebSep 6, 2024 · ALLSCHWIL, Switzerland, Sept. 06, 2024 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced its financial results for the first half of 2024 and provided a strategic business update.
WebAug 31, 2024 · ALLSCHWIL, Switzerland, Aug. 31, 2024 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and … WebApr 15, 2024 · Senior Analyst, Investor Relations. Job in New York City - Richmond County - NY New York - USA , 10261. Listing for: Travelers Canada. Full Time position. Listed on 2024-04-15. Job specializations: Finance.
WebEBX-002 – Spexis EBX-002 EBX-002 FOR NON-TUBERCULOUS MYCOBACTERIAL LUNG INFECTIONS Discovery Approval Explore pharma collaborations Relapse of NTM Infection is Common and Eradication Difficult: 90000 ESTIMATED US NTM PREVALENCE 69 PERCENT OF PATIENTS 65 OR OLDER 18 MONTHS OF ANTIBIOTIC TREATMENT
Web1 day ago · 13.04.2024 - Turkish Airline's Strategy and Targets for 2024-2033 Period. Growing significantly higher than the industry average over the last 20 years while having significant contributions to Türkiye's economy and labor market, Turkish Airlines is pleased to announce its strategic targets pertaining to the 100th year of its establishment. the union hotel everett pa menuWebAug 31, 2024 · ALLSCHWIL, Switzerland, Aug. 31, 2024 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and … the union hotel bloomington indianaWebApr 6, 2024 · SPEXIS AG : Press releases relating to SPEXIS AG Investor relations Swiss Exchange: POLN Swiss Exchange the union hotel purdue universityWebMay 15, 2024 · Spexis has raised a total of $88M in funding over 9 rounds. Their latest funding was raised on Feb 8, 2024 from a Debt Financing round. Spexis is registered … the union hotel gettysburg paWebMar 9, 2024 · Spexis AG. +41 61 567 16 00 [email protected] For Media: Dr. Stephan Feldhaus Feldhaus & Partner +41 79 865 92 56 [email protected] About Spexis Spexis is a clinical-stage biopharmaceutical company based in Allschwil, Switzerland, focused on rare diseases and oncology. the union hotel wagga waggaWeb2024 Full Year Results & Reports. Mayne Pharma 2024 Annual Report. FY21 Results Media Release. FY21 Results Presentation. the union hotel waggaWebMar 24, 2024 · Spexis Provides Business Update and Announces Financial Results for the Full-Year 2024 ACCESSWIRE March 24, 2024, 3:00 AM · 8 min read Successful launch of Spexis AG as a reverse merger of... the union hotel restaurant